These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9766464)
1. Discovery of MC-02,331, a new cephalosporin exhibiting potent activity against methicillin-resistant Staphylococcus aureus. Hecker SJ; Cho IS; Glinka TW; Zhang ZJ; Price ME; Lee VJ; Christensen BG; Boggs A; Chamberland S; Malouin F; Parr TR; Annamalai T; Blais J; Bond EL; Case L; Chan C; Crase J; Frith R; Griffith D; Harford L; Liu N; Ludwikow M; Mathias K; Rea D; Williams R J Antibiot (Tokyo); 1998 Aug; 51(8):722-34. PubMed ID: 9766464 [TBL] [Abstract][Full Text] [Related]
2. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases. Malouin F; Blais J; Chamberland S; Hoang M; Park C; Chan C; Mathias K; Hakem S; Dupree K; Liu E; Nguyen T; Dudley MN Antimicrob Agents Chemother; 2003 Feb; 47(2):658-64. PubMed ID: 12543674 [TBL] [Abstract][Full Text] [Related]
3. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. Piddock LJ; Traynor EA; Griggs DJ Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368 [TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli. Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of polyoxotungstates on the production of penicillin-binding proteins and beta-lactamase against methicillin-resistant Staphylococcus aureus. Fukuda N; Yamase T; Tajima Y Biol Pharm Bull; 1999 May; 22(5):463-70. PubMed ID: 10375165 [TBL] [Abstract][Full Text] [Related]
8. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus. Fasola EL; Fasching CE; Peterson LR J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469 [TBL] [Abstract][Full Text] [Related]
9. Studies on anti-MRSA parenteral cephalosporins. IV. A novel water-soluble N-phosphono type prodrug for parental administration. Ishikawa T; Nakayama Y; Tomimoto M; Niwa SI; Kamiyama K; Hashiguchi S; Iizawa Y; Okonogi K; Miyake A J Antibiot (Tokyo); 2001 Apr; 54(4):364-74. PubMed ID: 11426661 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci. Fujimura T; Yamano Y; Yoshida I; Shimada J; Kuwahara S Antimicrob Agents Chemother; 2003 Mar; 47(3):923-31. PubMed ID: 12604523 [TBL] [Abstract][Full Text] [Related]
11. [Molecular design of anti-MRSA drugs]. Hanaki H Nihon Rinsho; 1997 May; 55(5):1281-6. PubMed ID: 9155187 [TBL] [Abstract][Full Text] [Related]
12. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Neu HC Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915 [TBL] [Abstract][Full Text] [Related]
13. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties. Ishikawa T; Matsunaga N; Tawada H; Kuroda N; Nakayama Y; Ishibashi Y; Tomimoto M; Ikeda Y; Tagawa Y; Iizawa Y; Okonogi K; Hashiguchi S; Miyake A Bioorg Med Chem; 2003 May; 11(11):2427-37. PubMed ID: 12735989 [TBL] [Abstract][Full Text] [Related]
14. Novel cephalosporin derivatives possessing a bicyclic heterocycle at the 3-position. Part I: Synthesis and biological activities of 3-(benzothiazol-2-yl)thiocephalosporin derivatives, CP0467 and related compounds. Tsushima M; Iwamatsu K; Tamura A; Shibahara S Bioorg Med Chem; 1998 Jul; 6(7):1009-17. PubMed ID: 9730237 [TBL] [Abstract][Full Text] [Related]
15. Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. Truesdell SE; Zurenko GE; Laborde AL J Antimicrob Chemother; 1989 Apr; 23 Suppl D():13-9. PubMed ID: 2722720 [TBL] [Abstract][Full Text] [Related]
16. Penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: kinetic characterization of its interactions with beta-lactams using electrospray mass spectrometry. Lu WP; Sun Y; Bauer MD; Paule S; Koenigs PM; Kraft WG Biochemistry; 1999 May; 38(20):6537-46. PubMed ID: 10350472 [TBL] [Abstract][Full Text] [Related]
17. Affinity of E1077, a new cephalosporin, for penicillin-binding proteins of Staphylococcus aureus and its antistaphylococcal activity. Watanabe N; Katsu K J Antibiot (Tokyo); 1993 Nov; 46(11):1707-15. PubMed ID: 8270493 [TBL] [Abstract][Full Text] [Related]
18. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. Franciolli M; Bille J; Glauser MP; Moreillon P J Infect Dis; 1991 Mar; 163(3):514-23. PubMed ID: 1995724 [TBL] [Abstract][Full Text] [Related]
19. Reaction of soluble penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus with beta-lactams and acyclic substrates: kinetics in homogeneous solution. Graves-Woodward K; Pratt RF Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):755-61. PubMed ID: 9620879 [TBL] [Abstract][Full Text] [Related]
20. Emergence of methicillin-resistant clones from cephamycin-resistant Staphylococcus aureus. Okonogi K; Noji Y; Kondo M; Imada A; Yokota T J Antimicrob Chemother; 1989 Nov; 24(5):637-45. PubMed ID: 2599989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]